Loading clinical trials...
Loading clinical trials...
This is a single-arm, single-center phase II clinical study to explore the efficacy and safety of sintilimab combined with concurrent chemoradiation therapy as treatment in women with locally advanced...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The Affiliated Hospital of Xuzhou Medical University
NCT06380816 · Advanced Solid Tumours, Squamous Cell Carcinoma of Head and Neck, and more
NCT04389632 · Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, and more
NCT07138755 · NSCLC, Sintilimab, and more
NCT07416890 · Pirtobrutinib, Sintilimab, and more
NCT07324824 · Hepatocellular Carcinoma, Neoadjuvant Therapy, and more
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions